[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Pages 14954-14955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07232]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. to achieve 
expeditious commercialization of results of federally-funded research 
and development.

FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained 
by emailing the indicated licensing contact at the National Heart, 
Lung, and Blood, Office of Technology Transfer and Development Office 
of Technology Transfer, 31 Center Drive, Room 4A29, MSC2479, Bethesda, 
MD 20892-2479; telephone: 301-402-5579. A signed Confidential 
Disclosure Agreement may be required to receive any unpublished 
information.

SUPPLEMENTARY INFORMATION: Technology description follows.

Medical Device for Vascular Dilation

    A vascular dilator is commonly used in transcatheter cardiovascular 
intervention procedures. Commercially available vascular dilators have 
introducer sheaths with a finite thickness and mismatched diameter with 
the dilators. This causes uneven stretching of the trailing edge of the 
sheath and severe damage to the target vessels. This technology 
produces the specialized sheath with a shoulder that can be introduced 
percutaneously with an enhanced dilator into a broad range of diseased 
target vessels and chambers with reduced vascular injury. The shoulder 
helps to match the diameter of the introducer sheath so that there is a 
smooth transition between the dilator and the introducer sheath. The 
invention allows the dilator to be withdrawn in segments without 
disrupting the introducer sheath.

[[Page 14955]]

    Development Stage: Reduces vascular injury while using large-bore 
introducer sheaths in interventional cardiac procedures:

Transcatheter aortic valve replacement
Direct transthoracic access into the heart muscle for endografts

    Inventors: Dr. Robert Lederman (NHLBI), Dr. Ozgur Kocaturk (NHLBI), 
Dr. Adam Greenbaum (Henry Ford Hospital).
    Intellectual Property: HHS Reference No. E-759-2013/0; U.S 
Provisional Patent Application 61/890,961 filed October 15, 2013, 
International Patent Application PCT/US2014/060270 filed October 13, 
2014, U.S. Patent Application 15/025,336 filed March 28, 2016, European 
Patent 3057646 validated in Switzerland, Germany, France, the United 
Kingdom, and Ireland.
    Licensing Contact: Michael Shmilovich, Esq., CLP; 301-435-5019; 
[email protected].

    Dated: April 4, 2019.
Michael A. Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood 
Institute, Office of Technology Transfer and Development.
[FR Doc. 2019-07232 Filed 4-11-19; 8:45 am]
 BILLING CODE 4140-01-P